Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

Novo Nordisk

Status: Completed

Conditions: Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin detemir; Drug: insulin NPH

Study type: Observational

Funder types: Industry

Identifiers

NCT00715351

NN304-1896

Details and patient eligibility

About

This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control, weight change and hypoglycaemic effects in patients with type 2 diabetes with Levemir® compared to Insulatard® under normal clinical practice conditions.

Enrollment: 342 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 diabetes failing on oral blood glucose lowering therapy, and requiring insulin therapy.

Exclusion criteria

• Type 1 diabetes
• Previous use of insulin

Trial design

342 participants in 2 patient groups

A

Treatment:

Drug: insulin detemir

B

Treatment:

Drug: insulin NPH